Separate terms with OR to return results that match either term.
 
Clear All
10,000 Matching Results — Export these results
Click column titles once to sort ascending, and twice to sort descending.
Show Entries
NDC-11 (Package) NDC-9 (Product) Generic Name (Descending) Brand Name Strength SEER*Rx Category Major Class Minor Class Administration Route Package Effective Date Package Discontinuation Date Status
42658-0021-02 42658-0021 Daunorubicin hydrochloride Daunorubicin Hydrochloride 5.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jan. 27, 2021 In Use
42658-0021-92 42658-0021 Daunorubicin hydrochloride Daunorubicin Hydrochloride 5.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Dec. 19, 2022 In Use
42658-0021-91 42658-0021 Daunorubicin hydrochloride Daunorubicin Hydrochloride 5.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jan. 15, 2023 In Use
00143-9550-01 00143-9550 Daunorubicin Hydrochloride Daunorubicin Hydrochloride 5.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jan. 2, 2018 In Use
00143-9551-10 00143-9551 Daunorubicin Hydrochloride Daunorubicin Hydrochloride 5.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Jan. 2, 2018 In Use
42658-0007-01 42658-0007 Daunorubicin Hydrochloride Daunorubicin Hydrochloride 20.0 mg/4mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Oct. 1, 2016 Sept. 12, 2019 In Use
00024-5858-20 00024-5858 Daunorubicin Hydrochloride Daunorubicin Hydrochloride Chemotherapy Antitumor Antibiotic Anthracycline Intravenous June 23, 2014 Nov. 11, 2014 No Longer Used
00024-5858-22 00024-5858 Daunorubicin Hydrochloride Daunorubicin Hydrochloride Chemotherapy Antitumor Antibiotic Anthracycline Intravenous June 23, 2014 Nov. 11, 2014 No Longer Used
55390-0805-10 55390-0805 Daunorubicin Hydrochloride Daunorubicin Hydrochloride Chemotherapy Antitumor Antibiotic Anthracycline Intravenous June 28, 1996 April 30, 2013 No Longer Used
55390-0142-10 55390-0142 Daunorubicin Hydrochloride Daunorubicin Hydrochloride Chemotherapy Antitumor Antibiotic Anthracycline Intravenous July 13, 1998 Oct. 31, 2012 No Longer Used
00703-5233-11 00703-5233 Daunorubicin Hydrochloride Daunorubicin Hydrochloride 5.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous April 1, 2004 In Use
00703-5233-13 00703-5233 Daunorubicin Hydrochloride Daunorubicin Hydrochloride 5.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous April 1, 2004 In Use
00703-5233-91 00703-5233 Daunorubicin Hydrochloride Daunorubicin Hydrochloride 5.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous April 1, 2004 June 30, 2016 In Use
00703-5233-93 00703-5233 Daunorubicin Hydrochloride Daunorubicin Hydrochloride 5.0 mg/mL Chemotherapy Antitumor Antibiotic Anthracycline Intravenous April 1, 2004 June 30, 2016 In Use
55390-0108-01 55390-0108 Daunorubicin Hydrochloride Daunorubicin Hydrochloride Chemotherapy Antitumor Antibiotic Anthracycline Intravenous June 1, 1998 Sept. 30, 2013 No Longer Used
55390-0108-10 55390-0108 Daunorubicin Hydrochloride Daunorubicin Hydrochloride Chemotherapy Antitumor Antibiotic Anthracycline Intravenous June 1, 1998 Sept. 30, 2013 No Longer Used
61958-0301-01 61958-0301 Daunorubicin DaunoXome Chemotherapy Antitumor Antibiotic Anthracycline Intravenous April 8, 1996 July 1, 2011 No Longer Used
10885-0001-01 10885-0001 Daunorubicin DaunoXome Chemotherapy Antitumor Antibiotic Anthracycline Intravenous Feb. 13, 2012 April 16, 2016 No Longer Used
00003-0524-11 00003-0524 Dasatinib Sprycel 70.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral June 27, 2006 In Use
00003-0527-11 00003-0527 Dasatinib Sprycel 20.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral June 27, 2006 In Use
00003-0528-11 00003-0528 Dasatinib Sprycel 50.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral June 27, 2006 In Use
00003-0855-22 00003-0855 Dasatinib Sprycel 80.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Oct. 28, 2010 In Use
00003-0857-22 00003-0857 Dasatinib Sprycel 140.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Oct. 28, 2010 In Use
54868-5759-00 54868-5759 Dasatinib Sprycel 70.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral Feb. 12, 2007 In Use
00003-0852-11 00003-0852 Dasatinib Sprycel 100.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral June 3, 2009 Jan. 26, 2011 In Use
00003-0852-22 00003-0852 Dasatinib Sprycel 100.0 mg/1 Chemotherapy Tyrosine Kinase Inhibitor BCR-ABL Oral May 30, 2008 In Use
50419-0395-01 50419-0395 Darolutamide Nubeqa 300.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor Non-Steroidal Oral July 31, 2019 In Use
50419-0395-72 50419-0395 Darolutamide Nubeqa 300.0 mg/1 Hormonal Therapy Androgen Receptor Inhibitor Non-Steroidal Oral March 3, 2021 In Use
55513-0005-01 55513-0005 Darbepoetin alfa Aranesp 100.0 ug/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use
55513-0005-04 55513-0005 Darbepoetin alfa Aranesp 100.0 ug/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use
55513-0027-01 55513-0027 Darbepoetin alfa Aranesp 150.0 ug/.3mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Feb. 18, 2011 In Use
55513-0027-04 55513-0027 Darbepoetin alfa Aranesp 150.0 ug/.3mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use
55513-0014-01 55513-0014 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Oct. 1, 2001 Feb. 28, 2009 No Longer Used
55513-0015-01 55513-0014 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Aug. 19, 2002 April 30, 2009 No Longer Used
55513-0039-01 55513-0039 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Feb. 18, 2011 Feb. 28, 2009 No Longer Used
55513-0039-04 55513-0039 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent July 23, 2003 Feb. 28, 2009 No Longer Used
55513-0041-01 55513-0041 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Feb. 18, 2011 Feb. 28, 2009 No Longer Used
55513-0041-04 55513-0041 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent July 23, 2003 Feb. 28, 2009 No Longer Used
55513-0043-01 55513-0043 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Feb. 18, 2011 Dec. 31, 2008 No Longer Used
55513-0043-04 55513-0043 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent June 1, 2004 Dec. 31, 2008 No Longer Used
55513-0044-01 55513-0044 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Feb. 18, 2011 Feb. 28, 2009 No Longer Used
55513-0044-04 55513-0044 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent July 23, 2003 Feb. 28, 2009 No Longer Used
55513-0046-01 55513-0046 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Feb. 18, 2011 April 30, 2009 No Longer Used
55513-0046-04 55513-0046 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent July 23, 2003 April 30, 2009 No Longer Used
54868-5428-00 54868-5428 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Sept. 13, 2006 June 30, 2013 No Longer Used
54868-5429-00 54868-5429 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent March 20, 2008 June 30, 2013 No Longer Used
54868-5867-00 54868-5867 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent March 20, 2008 June 30, 2013 No Longer Used
55513-0006-01 55513-0006 Darbepoetin alfa Aranesp 200.0 ug/mL Ancillary Therapy Erythropoiesis-Stimulating Agent Intravenous, Subcutaneous Sept. 11, 2006 In Use
55513-0010-01 55513-0010 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Oct. 1, 2001 March 31, 2009 No Longer Used
55513-0010-04 55513-0010 Darbepoetin alfa Aranesp Ancillary Therapy Erythropoiesis-Stimulating Agent Oct. 1, 2001 March 31, 2009 No Longer Used

Found 10,000 results in 15 milliseconds — Export these results